Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1992 1
1996 1
2000 1
2001 3
2002 5
2003 4
2004 1
2005 5
2006 6
2007 1
2008 6
2009 5
2010 17
2011 14
2012 16
2013 10
2014 12
2015 16
2016 14
2017 12
2018 12
2019 12
2020 19
2021 16
2022 11
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, Invernizzi P, Jones D, Kruger FC, Lawitz E, Mayo MJ, Shiffman ML, Swain MG, Valera JM, Vargas V, Vierling JM, Villamil A, Addy C, Dietrich J, Germain JM, Mazain S, Rafailovic D, Taddé B, Miller B, Shu J, Zein CO, Schattenberg JM; ELATIVE Study Investigators’ Group; ELATIVE Study Investigators' Group. Kowdley KV, et al. N Engl J Med. 2024 Feb 29;390(9):795-805. doi: 10.1056/NEJMoa2306185. Epub 2023 Nov 13. N Engl J Med. 2024. PMID: 37962077 Clinical Trial.
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.
Nevens F, Andreone P, Mazzella G, Strasser SI, Bowlus C, Invernizzi P, Drenth JP, Pockros PJ, Regula J, Beuers U, Trauner M, Jones DE, Floreani A, Hohenester S, Luketic V, Shiffman M, van Erpecum KJ, Vargas V, Vincent C, Hirschfield GM, Shah H, Hansen B, Lindor KD, Marschall HU, Kowdley KV, Hooshmand-Rad R, Marmon T, Sheeron S, Pencek R, MacConell L, Pruzanski M, Shapiro D; POISE Study Group. Nevens F, et al. N Engl J Med. 2016 Aug 18;375(7):631-43. doi: 10.1056/NEJMoa1509840. N Engl J Med. 2016. PMID: 27532829 Free article. Clinical Trial.
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis.
Sanyal AJ, Anstee QM, Trauner M, Lawitz EJ, Abdelmalek MF, Ding D, Han L, Jia C, Huss RS, Chung C, Wong VW, Okanoue T, Romero-Gomez M, Muir AJ, Afdhal NH, Bosch J, Goodman Z, Harrison SA, Younossi ZM, Myers RP. Sanyal AJ, et al. Among authors: muir aj. Hepatology. 2022 May;75(5):1235-1246. doi: 10.1002/hep.32204. Epub 2022 Feb 7. Hepatology. 2022. PMID: 34662449 Free PMC article. Clinical Trial.
Hepatocellular Carcinoma Surveillance.
Jou JH, Muir AJ. Jou JH, et al. Among authors: muir aj. Clin Gastroenterol Hepatol. 2018 Jan;16(1):19-20. doi: 10.1016/j.cgh.2017.06.049. Epub 2017 Jul 8. Clin Gastroenterol Hepatol. 2018. PMID: 28694129 No abstract available.
Understanding the Complexities of Cirrhosis.
Muir AJ. Muir AJ. Clin Ther. 2015 Aug;37(8):1822-36. doi: 10.1016/j.clinthera.2015.05.507. Epub 2015 Jul 15. Clin Ther. 2015. PMID: 26188836 Free article. Review.
In the clinic. Hepatitis C.
Jou JH, Muir AJ. Jou JH, et al. Among authors: muir aj. Ann Intern Med. 2012 Dec 4;157(11):ITC6-1 - ITC6-16. doi: 10.7326/0003-4819-157-11-201212040-01006. Ann Intern Med. 2012. PMID: 23208180 Review. No abstract available.
A Big Step Forward in Hepatitis C Screening.
Kapila N, Muir AJ. Kapila N, et al. Among authors: muir aj. Clin Liver Dis (Hoboken). 2020 May 7;15(4):149-152. doi: 10.1002/cld.922. eCollection 2020 Apr. Clin Liver Dis (Hoboken). 2020. PMID: 32395241 Free PMC article. Review.
199 results